Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 285

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 8
Chunk 285
---
 of Warrant Agency Agreement with Continental Stock Transfer & Trust Co. dated February 13, 2023

    4.11(8)
     
    Form of Class D Common Stock Warrant dated February 5, 2024

    4.12(8)
     
    Form of Warrant Agency Agreement with Continental Stock Transfer & Trust Co. dated February 5, 2024

    4.13(9)
     
    Form of Class E Common Stock Warrant dated August 22, 2024

    4.14(10)
     
    Form of Class F Common Stock Warrant dated December 3, 2024

    4.15(10)
     
    Form of Class G Common Stock Warrant dated December 3, 2024

    4.16*
     
    Description of Securities

    10.1†(11)
     
    Revelation Biosciences, Inc. 2021 Equity Incentive Plan, as amended

    10.2†(1)
     
    Executive Employment Agreement between Revelation Biosciences, Inc. and James Rolke, effective July 27, 2021

    10.3†(1)
     
    Executive Employment Agreement between Revelation Biosciences, Inc. and Chester S. Zygmont, III, effective July 27, 2021

    10.4(1)
     
    Revelation Common Stock Warrant Issued to National Securities Corporation

    10.5(5)
     
    Securities Purchase Agreement dated January 23, 2022 by and between the Company and Armistice Capital Master Fund Ltd.

    10.6(7)
     
    Form of Securities Purchase Agreement dated February 9, 2023

    10.7(7)
     
    Form of Placement Agency Agreement Dated February 9, 2023

    10.8(8)
     
    Form of Securities Purchase Agreement dated February 1, 2024

    10.9(8)
     
    Form of Placement Agency Agreement dated February 1, 2024

    14.1(12)
     
    Code of Ethics

    14.2*
     
    Insider Trader Policy

    21.1(13)
     
    List of Subsidiaries.

    23.1*
     
    Consent of Baker Tilly US